The Patented AirJector-Vet® CO2 therapeutic treatment uses a warm mist of medical grade carbon dioxide to treat wounds directly and through the skin. The tissue under the wound responds to the CO2 by increasing blood flow through normal physiological mechanisms, a benefit that is based on the Bohr Effect.
University research studies on our product have clearly demonstrated the long term benefit of increased blood flow after a short series of treatments. These benefits include faster wound healing, remodeling of the vasculature, less risk of infection, and decreased inflammation.
Contact: Steve Maclin
Location: Virginia
Website: https://www.airjectorvet.com
Facebook:
Instagram:
Personal Interview Coming Soon!